Paul is currently the Chief Operating Officer for Kailos Genetics. Prior to Kailos, Paul was the CEO of OneOme, co-founded by Mayo Clinic. Paul joined OneOme in 2015 and lead his team in the effort to empower smarter prescription decisions through OneOme’s RightMed® medication optimization platform. While leading OneOme they were recognized in 2019 by Fast Company as top 22 of 50 most innovative companies in the world, #2 in bio-tech. Prior to joining OneOme Paul led global commercialization for Invitae, a San Francisco-based fastest growing hereditary disease diagnostics company. Previously, Paul served as Vice Chair of Global Business Development for Mayo Clinic and was the leader of Mayo Medical Laboratories’ global commercial team – one of the world’s largest full-service reference labs. Prior to that, Paul held leadership roles at what is now Zimmer-Biomet and at Boston Scientific, both highly competitive, cutting-edge, and fast-paced organizations. Paul serves on the Boards of Phenomix Sciences and The Redemption Project. Paul received his B.S. in business administration from the University of Wisconsin – Stout.